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Idiopathic infantilenystagmus (IIN) is agenetically heterogeneousdisorder, oftenassociatedwithFRMD7muta-
tions.As theappearanceof the retina is reported tobenormal basedonconventional fundusphotography, IIN is
postulated to arise from abnormal cortical development. To determine whether the afferent visual system is
involved in FRMD7 mutations, we performed in situ hybridization studies in human embryonic and fetal
stages (35 days post-ovulation to 9 weeks post-conception). We show a dynamic retinal expression pattern
of FRMD7 during development. We observe expression within the outer neuroblastic layer, then in the inner
neuroblastic layer and at 9 weeks post-conception a bilaminar expression pattern. Expression was also noted
within the developing optic stalk and optic disk. We identified a large cohort of IIN patients (n 5 100), and per-
formed sequence analysis which revealed 45 patients with FRMD7mutations. Patients with FRMD7mutations
underwent detailed retinal imaging studies using ultrahigh-resolution optical coherence tomography. The
tomograms were compared with a control cohort (n 5 60). The foveal pit was significantly shallower in
FRMD7 patients (P < 0.0001). The optic nerve head morphology was abnormal with significantly decreased
optic disk area, retinal nerve fiber layer thickness, cup area and cup depth in FRMD7 patients (P < 0.0001).
This study shows for the first time that abnormal afferent system development is associated with FRMD7
mutations and could be an important etiological factor in the development of nystagmus.
INTRODUCTION
Infantile nystagmus is characterized by involuntary to and fro
movements of the eyes, which is present at birth or manifesting
within the first few months of life. Nystagmus has an estimated
prevalence of 2.4 in 1000 (1) and is associated with significant
negative social stigma and poor visual function scores (2,3).
Thepathophysiologyof this disorder is unclear, althoughnumer-
ous hypotheses have been put forward. Previous animal models
for infantile nystagmus have suggested that axonalmisrouting at
the level of the chiasm could be a common mechanism (4). Cer-
tainly in patients with albinism and achiasma, both associated
with infantile nystagmus, misrouting of retinal ganglion cell
axons within the retinofugal pathway at the level of the chiasm
is observed. However, in many other forms of infantile nystag-
mus [e.g. aniridia, achromatopsia, idiopathic infantile nystag-
mus (IIN)] visually evoked potentials show interhemispherical
symmetry, suggestive of normal decussation of retinal ganglion
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cell axons (5). The fact that most forms of infantile nystagmus
arise due to mutations of genes expressed within the developing
retinawould argue in favor of anafferent abnormality.Moreover,
abnormal retinal phenotypes have been described in most of
these disorders (6–8). However, in IIN, other than reduced
visual acuity and an abnormal optokinetic response (9,10), no
overt ocular abnormality has been described. This has led to a
number ofmathematicalmodels suggesting that infantile nystag-
mus arises due to the instability of the neural integrator (11,12) or
the smooth pursuit system (13), rather than an afferent defect.
Mutations in FRMD7 are a major cause of IIN (14). The
FRMD7 gene is located at Xq26.2. In male subjects with patho-
genicFRMD7mutations, the disease is fully penetrant; however,
in females with heterozygous mutations, the penetrance is
≏53% (9). FRMD7 expression studies indicate anatomic path-
ways involved in the optokinetic reflex (9,10,14,15). However,
detailed spatiotemporal expression within developing retina
hasnot been characterized. FRMD7promotes neurite elongation
at the actin-rich growth cone ends through the modulation of
actin cytoskeleton (16,17).FRMD7 knockdownduring neuronal
differentiation alters neurite development, indicating a role in
axonogenesis or dendritogenesis (16). Recently, it has been
shown that CASK recruits FRMD7 to the plasma membrane to
promote neurite outgrowth during development of the oculo-
motor neural network and disruption of this interaction results
in nystagmus (17).
With the advent of optical coherence tomography (OCT), it is
possible to visualize the retina (18) in much greater detail than
conventional imaging techniques such as fundus photography.
Previously, the use of OCT (time domain) in nystagmus was
limited due to fixation instability, poor resolution and slow scan-
ning speeds. The newgeneration spectral-domainOCTs are able
to achieve faster scanning speeds and much higher resolution
than the time domain instruments. This has enabled imaging in
patients with infantile and acquired forms of nystagmus.
Recent OCT studies in multiple sclerosis have suggested that
this imaging modality has an important role in monitoring
disease activity (19) and the retinal changes reflect global CNS
processes (20). Similarly, OCT studies in infantile nystagmus
have highlighted the spectrum of abnormal retinal phenotypes
and its role in predicting visual acuity (7). We have recently
shown that we can obtain reliable thickness measurements in
patients with nystagmus using an ultrahigh-resolution OCT
with very fast scanning speeds (21). During foveal pit formation
(area of high acuity), the inner retinal layers are displaced centri-
fugally (away from the future foveal pit), while the cone photo-
receptors migrate centripetally (toward the future foveal pit). As
the cone photoreceptors migrate toward the fovea, they also
undergo specialization, which involves lengthening of the
outer segment. This allows increased packing of the cone photo-
receptors with highest concentration at the fovea (22,23). OCT
allows accurate documentation of the stages of arrested retinal
development (7). The normal retinal laminar structure and
foveal pit visualized using an ultrahigh-resolution OCT is
shown in Supplementary Material, Figure S1.
To date, there have been no studies investigating systematic-
ally the retinal morphology in patients with IIN associated with
FRMD7 mutations. Studying the neural substrates involved in
disease pathogenesis can point to potential therapeutic targets.
Hence, we aimed to carefully investigate the afferent pathway,
using high-resolution in situ hybridization techniques and
retinal imaging in patients with FRMD7mutations.
RESULTS
FRMD7 expression
We show a dynamic expression pattern of FRMD7mRNA in the
developing neural retina between Carnegie stages CS15–CS23
and 9 weeks postconception (wpc). Carnegie Stages 15–23 rep-
resent the embryological stages from 33 days post-conception
(dpc) to 56 dpc. At CS15 (33 dpc) restricted FRMD7 expression
is seenwithin the outer neuroblastic layer (Fig. 1). Development
of the retinal ventricular zone (VZ) is similar to the cortical VZ.
Postmitotic cells fromVZmigrate to the future ganglion cell and
inner nuclear layers (24). These neurons are closely apposed to
radial glia, their processes extending to the vitreal surface. At
CS16 (37 dpc) FRMD7 expression is seen within the inner neu-
roblastic layer. Differentiation of the retina begins at the optic
disk, and then extends peripherally toward the rim. Thus, the
staining pattern is different between central and peripheral
retina at CS16 and CS19 (47 dpc). At CS23 (56 dpc) a bilaminar
expression pattern emerges, which is evident by 9 wpc. There is
FRMD7 expression in the optic stalk at CS15, CS16 and CS19,
while, at 9 wpc, expression is confined to the optic nerve sheath.
Based on our FRMD7 expression results, we assessed retinal
structure in FRMD7 patients by measuring foveal pit depth
and central macular and photoreceptor outer segment thickness.
Since FRMD7 regulates neurite outgrowth, we also measured
retinal nerve fiber layer thickness, and optic disk area, a
measure of optic nerve fiber count (25).
Retinal phenotypes associated with FRMD7 mutations
OCT identified an obvious failure of inner retinal cells tomigrate
away from the foveal pit (foveal hypoplasia) in 12 of 45 patients
(Supplementary, Material, Table S2). The incursion of inner
retinal layers posterior to the foveola represents the hallmark
of foveal hypoplasia. Foveal hypoplasia was associated with
missense, splice and nonsense mutations (Fig. 2), without
obvious genotype–phenotype correlations. The c.285-118C .
T and c. 206-5T . A represent novel mutations. The
c.285-118C . T mutation is predicted to activate a cryptic
splice donor within intron 4 (26). The c. 206-5T . A mutation
is predicted to result in obliteration of the splice acceptor site
in intron 3. The splice variants c.205 + 2T. G has previously
been described (14). The c.205 + 2T . G is within the con-
served splice donor residues (position + 1 and +2) and is thus
predicted to be pathological by classical exon skipping and
nonsense-mediated decay (14). Furthermore, the translational
products are likely to be subject to nonsense-mediated decay.
The missense mutations resulting in amino acid variants
A266P and C271Y are predicted to be pathological (10,14).
The C271Y is predicted to destabilize the FRMD7 protein by
the introduction of a larger amino acid within restricted areas
of the protein, whereas A266P is predicted to disrupt a helical
domain within the wild-type protein (10,14). The nonsense
mutation resulting in the amino acid variant R335X is predicted
to be pathological due to introduction of a premature stop codon
Human Molecular Genetics, 2014, Vol. 23, No. 15 4087
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resulting in a truncated protein (10,14). In vitro studies have
shown nuclear localization associated with R335X (17,27).
The foveal pit depthwas significantly decreased in the FRMD7
patients in comparison with the controls (mean difference ¼
24.6 mm, P , 0.0001). The central macular thickness was sig-
nificantly increased in patients with FRMD7mutations in com-
parison with controls (mean difference ¼ 12.1 mm, P ¼
0.0014). A shallow foveal pit and increased central macular
thickness are consistent with foveal hypoplasia (Fig. 3). We
did not identify any cases of fovea plana (i.e. anatomic lack of
foveal pit). None of the control subjects had foveal hypoplasia.
In order to assess the maturity of the outer retina and degree
of photoreceptor specialization, we assessed the cone outer
segment length. We noted that the cone outer segment was
significantly decreased in length in patients with FRMD7muta-
tions when compared with controls (mean difference ¼ 8.3 mm,
P, 0.0001).
Based on the FRMD7 expression within the optic nerve head
in humans, we performed quantitative measurements in the
patients with FRMD7 mutations and compared it with the
controls. e identified that the average peripapillary retinal nerve
fiber layer thickness was significantly decreased in patients with
FRMD7 mutations when compared with controls (mean
difference ¼ 18.7 mm, P, 0.0001). Similarly, the optic disk
area was significantly decreased in patients in comparison with
controls (mean difference ¼ 0.37 mm2, P, 0.0001). The optic
Figure 1. FRMD7 mRNA expression profile in developing human neural retina. (A) Low-magnification image of the embryos from CS 15, 16, 19, 23 and 9 weeks
postconception (wpc). (B) Dynamic expression pattern; expression initially confined to the outer neuroblastic layer (ONBL) at CS15, subsequently expression seen
within the inner neuroblastic layer (INBL). Bilaminar expression pattern at 9 wpc (arrows). Expression within the developing optic stalk (OPS) at CS15, CS16 and
CS19. Expression restricted to the optic nerve sheath (ONS), absent in developing optic disk (OD) at 9 wpc. Peripheral neural retina is the last to differentiate and
laminate, hence differential expression between central and peripheral neural retina, most evident at CS16 and CS19. Sense images shown below the antisense
images; once pigmentation occurs, RPE appears as false positive for expression at CS16 onward. Low-magnification image scale bar: 500 mm high-magnification
image scale bar: 200 mm.
Figure2.FRMD7mutations associatedwith foveal hypoplasia.Allmutationswerepredicted to disrupt theFERMdomainor theFERM-adjacent (FA)domain.Splice
variants are shown in brackets. The resulting amino acid variations for missense and nonsense mutations are shown.
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nerve cup was shallower (mean difference ¼ 0.31 mm, P ¼
0.0001) with decreased cup area (mean difference ¼ 0.26 mm,
P ¼ 0.0002) in patients with FRMD7mutations (Fig. 4).
The mean visual acuity in the FRMD7 cohort was 0.20
LogMAR. There was no significant difference in visual acuity or
OCTmeasurements betweenmale and female patients (P. 0.05).
DISCUSSION
This study shows for the first time that patients with IIN have
retinal and optic nerve changes. This raises an interesting possi-
bility that afferent defects during early development could
underlie the development of childhood nystagmus. Foveal hypo-
plasia is typically associated with inherited developmental
retinal disorders such as albinism, PAX6-related phenotypes
and achromatopsia (7,28). Infantile nystagmus is a common
feature of these conditions.During fovea formation, there is cen-
trifugal displacement of inner retinal cells as the foveal pit
deepens, and centripetal migration and specialization of cone
photoreceptors (22,23). In patients with FRMD7 mutations,
impaired growth cone guidance (14,16) could lead to retinal
neuronmigratory defects such as foveal hypoplasia anddevelop-
mental abnormalities of the optic nerve head. This is consistent
with expression patterns we observed in the developing retina
and optic nerve.
The predominant clinical features observed in patients with
FRMD7 mutations are reduced visual acuity and abnormalities
of the optokinetic response (9,10,15). The novel finding of
foveal hypoplasia could be the basis of these abnormalities pre-
viously described. Typically, patients with FRMD7 mutations
tend to have better visual acuity compared with patients with al-
binism (29). The foveal hypoplasia observed in patients with
FRMD7 mutations is much milder (i.e. patients with foveal
hypoplasia had at least a rudimentary pit—Grade 1 foveal hypo-
plasia) in comparison with albinism, where the majority of
patients had no foveal pit (Grade 3 foveal hypoplasia) (7). This
could explain the better visual acuity previously reported in
FRMD7 groups than in albinism (29).
Previously, there have been no reports of retinal defects
in patients with idiopathic nystagmus. This is likely due to the
limitations associated with retinal imaging. The advent of
spectral-domain optical coherence tomography has opened
ultrahigh-resolution imaging at high speeds. In this study, we
Figure3.Foveal hypoplasiawithFRMD7mutations. (A)Arrested retinal developmentwithFRMD7mutations shownby shallowfoveal pit (a), failureof inner retinal
cell migration (b), failure of cone photoreceptor specialization (c) and smaller retinal nerve fiber layer (d). (B) 3D thickness maps showing rudimentary foveal pit
compared with controls. Central macular thickness (C), foveal pit depth (D) and outer segment thickness (E) were significantly different compared with controls.
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have used one of the highest resolution commercially available
instruments (axial resolution, 3 mm) with the fastest scanning
speed (52 000 A-scans/s).We have shown that, using this instru-
ment,we are able toperform reproducibleOCTmeasurements in
patients with nystagmus (21).
Further studies will be required to investigate how FRMD7
mutations lead to the morphological retinal changes described
in this study. Further studies in an animal model would be the
next logical step in understanding the pathogenesis of this dis-
order. The FRMD7 knockout mouse model would be suitable
model for further investigating the optic nerve changes and
nerve fiber layer changes described in this study. However, a
drawback of the mouse model is the lack of a fovea, so compar-
isons with the human visual system would be difficult. Thus, it
would not be possible to deduce how FRMD7 mutations lead
to foveal hypoplasia. There have been no detailed neuroimaging
studies in patients with FRMD7 mutations. Therefore, it is
unclear whether abnormal retinal development in FRMD7
patients would lead to abnormal cortical development. Further
neuroimaging studies coupled with OCT studies in humans as
well as histological studies in FRMD7 knockout mouse would
be needed to assess how the afferent abnormalities might
affect neural circuitry within the oculomotor system.
To date there are only two genes, PAX6 and SLC38A8, muta-
tions of which can result in isolated foveal hypoplasia (30–32).
PAX6mutations have been reported to be a rare cause of isolated
foveal hypoplasia (28). PAX6 mutations can also be associated
with aniridia, optic nerve hypoplasia and brain abnormalities
(33,34). SLC38A8 mutations are also associated with
developmental delay and pervasive developmental disorder-like
features (30). Recently, Perez et al. used a combination of
linkage analysis and whole-exome sequencing to identify a mu-
tation in SLC38A8 that results in infantile nystagmus and iso-
lated foveal hypoplasia (30). However, the mutation was only
found in a community of Jewish Indian ancestry, thus represent-
ing a very rare autosomal recessive cause of foveal hypoplasia.
Poulter et al. expanded the mutation and phenotypic spectrum
associated with SLC38A8, showing that mutations were also
associated with optic nerve decussation defects, anterior
segment abnormalities, but no other characteristics of albinism
such as pigmentary abnormalities, including iris transillumin-
ation defects (32). SLC38A8 is expressed within the retina and
fetal brain (30,32). With the advent of next generation sequen-
cing technologies, it will become easier to identify more genes
associated with foveal hypoplasia, thus providing greater under-
standing of the genetic basis of foveal development. In patients
with FRMD7mutations, there have been no reports of brain ab-
normalities or other ocular phenotypes to date.Wedid not screen
for PAX6 mutations, since clinically there were no features to
suggest PAX6-related phenotype. Moreover, it is also unlikely
that our patients had PAX6 mutations, since, as we have
shown, in patients with PAX6 mutations the nystagmus form is
very different, usually with a vertical component (31). None of
the families had male-to-male inheritance to suggest autosomal
dominant nystagmus, as in PAX6, and all families were compat-
ible with X-linked inheritance, as occurs in FRMD7mutations.
Our study suggests that FRMD7mutations can present as iso-
lated foveal hypoplasia. Therefore, patients presenting with
Figure 4.Optic nerve changes with FRMD7mutations. (A) Normal optic nerve head shown for comparison with FRMD7mutations (B). Optic disk area (C), nerve
fiber layer thickness (D), cup area (E) and cup depth (F) were significantly different compared with controls.
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infantile nystagmus and foveal hypoplasia in the absence of
other ocular anomalies should be considered for screening of
FRMD7 mutations. The study raises an interesting possibility
that early sensorimotor integration failure underlies IIN devel-
opment. Prior to this study, there have been no structural abnor-
malities associated with IIN, and IIN was thought to arise from
abnormal cortical development. The findings in this study
suggest that arrested retinal development is an important etio-
logical factor in the development of nystagmus. Whether this
in turn affects cortical development would need further study.
MATERIALS ANDMETHODS
Tissue in situ hybridization
Spatiotemporal FRMD7 retinal expression was investigated by
in situ hybridization (10,35) on human embryonic and fetal
tissue.Humanembryoswere obtainedwith appropriatematernal
written consent and approval from the Newcastle and North
Tyneside NHS Health Authority Joint Ethics Committee.
HDBR is regulated by the UK Human Tissue Authority (HTA;
www.hta.gov.uk) and operates in accordance with the relevant
HTA Codes of Practice.
Samples were fixed overnight at 48C in 0.1 M phosphate buf-
fered saline (PBS) containing 4% paraformaldehyde (PFA;
Sigma–Aldrich, Poole, UK). The embryos were classified into
Carnegie stages (36,37).
ISH was performed as previously described (38) with some
modifications. Paraffin sections were dewaxed and rehydrated
before being incubated with proteinase K (20 mg/ml; Sigma–
Aldrich) for 8 min at room temperature. Sections were fixed in
4% PFA/PBS for 20 min, washed in PBS, and treated with
0.1 M triethanolamine (Sigma–Aldrich, pH 8.0)/0.25% acetic
anhydride (Sigma–Aldrich)/0.2% HCl for 10 min, dehydrated
in ethanol and air-dried. DIG-labeled probes (300 ng) were
used per 100 ml of DIG Easy Hyb mixture (Roche, Lewes,
UK). Probe/Hyb mix (200 ml) was used per slide, covered with
glass coverslips. Slides were incubated in a hybridization
chamber overnight at 688C, rinsed in 5× standard sodium
citrate (SSC; pH 7.2) at 658C to remove coverslips, followed
by three washes at 508C (2× SSC twice and 0.2× SSC once),
followed by onewashwith 0.2× SSC once at room temperature.
After briefly rinsing in 0.1 M Tris (pH 7.6)/0.15 M NaCl (Buffer
1) and blocking with 10% fetal calf serum (Invitrogen)/Buffer 1
for 1 h at room temperature, sections were incubated with
anti-DIG antibody (Roche; diluted 1: 1000 in 2% FCS/Buffer
1) overnight at 48C. Sections were washed in Buffer 1 for 6 ×
30 min. Detection of probes/anti-DIG antibody was achieved
by addition of NBT/BCIP solution (Roche; 20 ml/ml) in 0.1 M
Tris (pH 9.5)/0.1 M NaCl (Buffer 2). The color reaction was
developed in the dark for several hours to overnight and termi-
nated by rinsing slides in Buffer 2 and then distilled water. Sec-
tions were mounted in Aquamount. Comparison of staining
between sense and antisense probes was carried out to ensure
specificity. Human embryos ranging in age from Carnegie
Stage 15 (35 days postovulation) to 9 weeks postconception
were obtained from the MRC/Wellcome Trust funded Human
Developmental Biology Resource at Newcastle University
(HBDR, http://www.hdbr.org).
Subjects
Patientswith nystagmuswere recruited fromdifferent sites:Uni-
versity Hospitals Leicester (UK),Moorfields EyeHospital (UK)
and Ghent University Hospital (Belgium). Patients underwent
detailed ophthalmic examinations, eye movement recordings
and electrodiagnostic tests. A diagnosis of IIN was obtained
based on (i) normal electrodiagnostic tests (electroretinograms
and visually evoked potentials based on ISCEV standards), (ii)
onset of nystagmus (horizontal, conjugate oscillation of the
eyes)within thefirst 6monthsof life (iii) no iris transillumination
defects on slit lamp biomicroscopy and (iv) normal color vision
on Ishihara testing. Informed consent was obtained from all
participants in accordance to the Declaration of Helsinki and
all protocols were approved by the local ethics committee. We
identified a total of 100 IIN patients based on these diagnostic
criteria. All IIN patients underwent sequence analysis to identify
FRMD7 mutations (see Materials and Methods). We wanted
to investigate the retinal morphology in a homogeneous
population; therefore, we only included patients with FRMD7
mutations. Forty-five patients with FRMD7 mutations were
recruited for subsequent high-resolution retinal phenotyping
using optical coherence tomography.
Thecontrol cohort (n¼ 60;meanage¼ 35.0years,SD¼ 13.8,
range ¼ 5–62 years) was age, race and gender matched to the
FRMD7 cohort (n¼ 45; mean age ¼ 34.7 years, SD ¼ 17.4,
range ¼ 7–79 years). The control cohort consisted of 32 males
and 28 females. The FRMD7 cohort consisted of 25 males and
20 females. Patients with FRMD7 mutations had only small re-
fractive errors within +3 D. The inclusion criteria for controls
were refractive errors within +3 D. During the scan protocol,
refractive error data were entered in SOCT before examination.
The SOCT software performs a refractive compensation.
Each control subject underwent an ophthalmic examination to
exclude significant ophthalmic pathologies. There was no
history of retinopathy of prematurity or other ophthalmological
or neurological pathology in either cohort.
DNA sequencing and analysis
Primers were designed to amplify the coding exons and the
intron–exon boundaries of the FRMD7 gene (Accession ID:
NG_012347.1) (Supplementary Material, Table S1). All the
coding exons and splice junctions were Sanger sequenced
bidirectionally in affected subjects. Mutation analysis software
SeqMan Pro v11.2 (DNAStar, Madison, WI, USA) was used for
base calling and alignment of the contigs. Base position + 1 cor-
responded toA of the translation initiation codonATG (Genbank
file: NM_194277.2). Intronic sequence changes were identified
based on the FRMD7 genomic sequence (NG_012347.1) and
amino acid changes were identified based on the reference
protein sequence (NP_919253.1). Allelic variants were reported
according to Human Genome Variation Society guidelines.
Allelic variations were assessed against the sequence data from
300 male controls (without nystagmus) and dbSNP database
(http://www.ncbi.nlm.nih.gov/SNP/; dbSNP Build ID: 137).
Novel intronic variants were also assessed using the Alternative
Splice Site Predictor (26). Disease causing mutations were iden-
tified basedonvariant segregationwith the phenotype, absence of
the variants in the control samples and control databases and
Human Molecular Genetics, 2014, Vol. 23, No. 15 4091
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predicted effects on protein structure. The variant data have been
submitted to LOVD database (www.LOVD.nl/MR).
Optical coherence tomography
Ultrahigh-resolution spectral-domain OCT (SOCT Copernicus
HR; OPTOPOL Technology SA) was used to acquire tomo-
grams from both eyes of the patients (n ¼ 45) and controls
(n ¼ 60).We have previously described the acquisition and ana-
lysis methods used in patients with nystagmus (7,21). This OCT
uses a superluminescent light emitting diode at a central wave-
length of 855 nm. A 3D scan program (743 × 75, A × B) was
used to capture the foveal and parafoveal regions. The scanning
window covered a 7 × 7 mm retinal area centered at the fovea.
For optic nerve head acquisition, the same scan parameters
were used; however, the fixation spot was altered and the scan
window was centered at the optic nerve head. The terminations
of the retinal pigment epithelium (RPE) were used to determine
the borders of the optic disk; an anterior offset of 150 mm from
the RPE was used to determine the borders of the cup. The
acquired images were analyzed using the SOCT software
(version 4.1) and custom scripts in ImageJ software (39)
(Rasband, W.S., ImageJ, U.S. National Institutes of Health,
Bethesda, MD, USA, http://imagej.nih.gov/ij/, 1997–2013).
We have previously reported the reproducibility of OCT acqui-
sition and analysis in patients with nystagmus (21).
The effective axial and transverse resolutions obtained using
this machine were ≏3 and 12 mm, respectively, with a scanning
speed of 52 000 A-scans/s. The foveal and optic nerve head
B-scanswere segmented and analyzed formorphological abnor-
malities and thickness measurements. These included foveal
pit depth, central macular thickness, outer segment thickness,
peripapillary nerve fiber layer thickness, disk area, cup area
and cup depth.
Statistical analyses
A linear mixed model was used to assess whether there were
significant differences between the control cohort and patients
with FRMD7 mutations for retinal thickness measurements
(foveal pit depth, central macular thickness, outer segment
thickness, nerve fiber layer thickness, optic disk area, optic cup
area and cup depth). Age, gender and race were used as
random effects factors. Statistical analyses were performed in
IBMw SPSSw Statistics version 20. The diamond plots were
used in figures to show differences in thickness measurements.
They represent the 95%confidence intervalswith the line bisect-
ing the diamond representing the mean.
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